Alendronate
Alendronate is a pharmaceutical drug with 85 clinical trials. Currently 3 active trials ongoing. Historical success rate of 86.1%.
Success Metrics
Based on 62 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
25
Mid Stage
44
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
84.9%
62 of 73 finished
15.1%
11 ended early
3
trials recruiting
85
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Precision Medicine Approach for Osteoporosis - Follow Up Study
Small Trial of Alendronate Impact on the Reservoir of HIV
Romosozumab in Women With Chronic SCI
To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk
Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover
Clinical Trials (85)
Precision Medicine Approach for Osteoporosis - Follow Up Study
Small Trial of Alendronate Impact on the Reservoir of HIV
Romosozumab in Women With Chronic SCI
To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk
Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover
Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis
A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Alendronate in Healthy Adult Participants (MK-0616-027)
A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)
A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)
Treatment Exercises With Core Stability and Dynamic Resistance Exercise for Postmenopausal Women With Osteoporosis
Bisphosphonates for Prevention of Post-Denosumab Bone Loss
Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis
Testosterone and Alendronate in Hypogonadal Men
Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants
Comparative Antiresorptive Efficacy Discontinuation of Denosumab
Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide
Denosumab vs Alendronate After Vertebroplasty
Renal Osteodystrophy: An Individual Management Approach
Efficacy and Safety of Minodronate in Patients With Low Back Pain
Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 85